Company Quick10K Filing
BioSolar
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-03-09
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-21
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-19
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-09
10-K 2016-12-31 Filed 2017-03-17
10-Q 2016-09-30 Filed 2016-11-08
10-Q 2016-06-30 Filed 2016-08-08
10-Q 2016-03-31 Filed 2016-05-11
10-K 2015-12-31 Filed 2016-03-04
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-07
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-03-23
10-Q 2014-09-30 Filed 2014-10-29
10-Q 2014-06-30 Filed 2014-08-01
10-Q 2014-03-31 Filed 2014-05-06
10-K 2013-12-31 Filed 2014-03-24
10-Q 2013-09-30 Filed 2013-10-25
10-Q 2013-06-30 Filed 2013-07-26
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-02-26
10-Q 2012-09-30 Filed 2012-11-02
10-Q 2012-06-30 Filed 2012-08-03
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-30
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-05
10-Q 2011-03-31 Filed 2011-05-11
10-K 2010-12-31 Filed 2011-03-22
10-Q 2010-09-30 Filed 2010-11-05
10-Q 2010-06-30 Filed 2010-07-29
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-24
8-K 2020-06-16
8-K 2020-06-05
8-K 2020-05-18
8-K 2020-04-23
8-K 2020-04-09
8-K 2020-04-01
8-K 2020-03-12
8-K 2020-03-02
8-K 2020-02-14
8-K 2020-01-20
8-K 2019-12-23
8-K 2019-12-11
8-K 2019-12-10
8-K 2019-12-02
8-K 2019-10-29
8-K 2019-10-01
8-K 2019-09-04
8-K 2019-09-03
8-K 2019-08-08
8-K 2019-07-25
8-K 2019-07-16
8-K 2019-06-11
8-K 2019-06-06
8-K 2019-04-25
8-K 2019-04-16
8-K 2019-04-05
8-K 2019-02-22
8-K 2019-01-23
8-K 2018-12-10
8-K 2018-10-15
8-K 2018-09-04
8-K 2018-07-23
8-K 2018-06-14
8-K 2018-02-26

BioSolar Financials

BSRC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
CDTI Advanced Materials (CDTI) 2,402 31% 0.2 -66% 7,763 4,765 14,253 4,426 -5,095 -3,933 -852
Alpine 4 Technologies (ALPP) 2,373 25% 2.8 -4% 26,273 37,478 20,690 5,148 -1,162 2,666 7,436
Quantrx Biomedical (QTXB) 2,361 -13.3 -81% 384 2,200 0 0 -309 -166 2,206
Evolutionary Genomics (FNAM) 2,353 0% -4.2 -12% 4,432 975 116 0 -538 -508 2,135
Mount Tam Biotechnologies (MNTM) 2,228 -1.8 -6,794% 20 2,877 0 0 -1,333 -1,248 2,219
Electronic Systems Technology (ELST) 2,228 54% -46.8 -2% 1,982 93 1,141 613 -49 -43 2,028
BioSolar (BSRC) 2,213 2.1 1,165% 145 14,186 0 0 1,685 2,403 4,975
Innerscope Hearing Technologies (INND) 2,206 57% -0.7 -118% 4,220 8,205 657 372 -4,980 -4,663 3,150
Remsleep Holdings (RMSL) 2,194 -0.8 -1,529% 197 1,096 0 0 -3,016 -2,978 2,343
iSIGN Solutions (ISGN) 2,189 0% -2.8 -549% 148 5,210 639 0 -812 -762 2,152
OLB Group (OLBG) 2,187 0% -11,960.1 -11% 11,509 14,314 7,650 0 -1,282 -1 11,661
Prestige Capital (PGEC) 2,166 -109.1 -15,390% 0 199 0 0 -20 -20 2,166
Egalet (EGLT) 2,150 0% -3.1 -17% 239,048 190,645 60,230 0 -40,416 -30,381 93,425
Enviro Technologies (EVTN) 2,147 30% -3.1 -38% 1,895 2,998 156 46 -715 -701 2,151
Mountain High Acquisitions (MYHI) 2,122 100% -0.4 -1,517% 323 285 79 79 -4,904 -4,818 2,026
Dougherty's Pharmacy (MYDP) 2,079 33% -95.8 -40% 8,462 10,364 27,384 9,125 -3,358 -41 3,927
Cloudweb (CLOW) 2,079 -41.9 0 312 0 0 -49 -52 2,188
Nulife Sciences (NULF) 2,078 1% -0.6 -5,624% 62 1,925 11 0 -3,506 -3,465 2,049
Innovative Designs (IVDN) 2,051 29% -3.5 -38% 1,598 755 271 79 -610 -600 2,101
Sangui Biotech International (SGBI) 2,015 100% -7.2 -591% 46 -8 77 77 -271 -276 1,994

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash8335526374324311412428715895789817425315920323024524520916218113111910311310283667374
Accounts Receivable
Inventory
PP&E797979798282828282823937838383833429292929313131313131373737373737
Assets306248277294288238144231233391253198244265361436335372447396369317296301222219234226215153138148145
Accounts Payable118418837915102150121227235191617251413323613361160
Long-Term Debt2,1942,2982,4362,6022,7372,7962,8392,836
Liabilities18711122052446246739356066269401,7963,68321,66614,1899,0979,2379,41110,2036,9626,8987,9158,4497,8748,21837,66028,06517,15313,30713,91614,186
Stockholders' Equity26022417633-101-393-440-543-353-428-696-1,530-3,322-21,230-13,854-8,725-8,790-9,014-9,834-6,644-6,602-7,614-8,228-7,655-7,985-37,434-27,850-17,000-13,169-13,768-14,041
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue00000000000000000000000000000000
Cost of Revenue
Gross Profit
R&D910103443641112503535367544806256285278659534091754560
SG&A31629628927617717516918313817415915611213211813713153552553753549951249143922196108107106118103
Tax00-1000000000000000000000000000
Net Income-327-308-312-182-214-289-429-243-466-62-176-16-844245-18,1027,3294,736-478-720-1,2492,647-371-1,669-1,104359-572-29,5579,5843,481-940-856
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-174-118-87-67-140-84-98-144-128-58-118-164-153-144-204-186-227-157-174-113-141-139-180-149-177-201-163-169
Cash Investing-1-1-30-7-00-50-5-29-0-5-120-00-0-2-5-000-60000
Cash Financing1261301012515815610800185185225902302551731758295158163165166184170170